A Novel Compound Heterozygous Mutation in Progressive Familial Intrahepatic Cholestasis (PFIC) 4: A Rare Case Report With Literature Review

进行性家族性肝内胆汁淤积症(PFIC)4 型中一种新型复合杂合突变:一例罕见病例报告及文献复习

阅读:1

Abstract

A 12-year-old female, resident of western India, presented with a history of pruritus associated with jaundice for two months. On presentation, she had icterus with mild palpable hepatomegaly. Investigations revealed direct hyperbilirubinemia and elevated transaminases, while gamma-glutamyl transferase levels were normal. Serology for anti-hepatitis A, E, B, and C were negative. Autoimmune markers such as antinuclear antibody, smooth muscle antibody, and anti-liver kidney microsomal antibody were negative. Serum IgG levels were within the normal range. A normal magnetic resonance cholangiopancreatography ruled out any ductal abnormalities. A liver biopsy was also conducted but proved to be inconclusive. Despite extensive workup, the diagnosis remained unclear. However, genetic testing through whole exome sequencing identified a novel compound heterozygous variation, a novel in exon 5 and exon 4 of the Tight-Junction Protein 2 gene, and confirmed the diagnosis of cholestatic liver disease as progressive familial intrahepatic cholestasis type 4. This case highlights the importance of genetic testing for diagnosing cholestatic liver diseases, especially when conventional tests do not provide a clear diagnosis. Whole exome sequencing revealed a novel mutation in the TJP2 gene, ultimately confirming the diagnosis of PFIC4.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。